Literature DB >> 12538417

Infectious serology and atherosclerosis: how burdensome is the risk?

Joseph B Muhlestein, Jeffrey L Anderson.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12538417     DOI： 10.1161/01.cir.0000043909.78380.a0

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.

Authors:  Christian M Jespersen; Bodil Als-Nielsen; Morten Damgaard; Jørgen Fischer Hansen; Stig Hansen; Olav H Helø; Per Hildebrandt; Jørgen Hilden; Gorm B Jensen; Jens Kastrup; Hans Jørn Kolmos; Erik Kjøller; Inga Lind; Henrik Nielsen; Lars Petersen; Christian Gluud
Journal:  BMJ       Date:  2005-12-08

2.  Salivary immunoglobulins and prevalent coronary artery disease.

Authors:  S Janket; J H Meurman; A E Baird; M Qvarnström; P Nuutinen; L K Ackerson; J Hong; P Muthukrishnan; T E Van Dyke
Journal:  J Dent Res       Date:  2010-02-22       Impact factor: 6.116

3.  Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.

Authors:  Kerry W S Ko; David B Corry; Cory F Brayton; Antoni Paul; Lawrence Chan
Journal:  Biochem Biophys Res Commun       Date:  2009-04-22       Impact factor: 3.575

4.  Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX.

Authors:  Rohina Rubicz; Charles T Leach; Ellen Kraig; Nikhil V Dhurandhar; Barry Grubbs; John Blangero; Robert Yolken; Harald Hh Göring
Journal:  BMC Res Notes       Date:  2011-10-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.